tiprankstipranks
Dermata Therapeutics (DRMA)
NASDAQ:DRMA
US Market
Holding DRMA?
Track your performance easily

Dermata Therapeutics (DRMA) Financial Statements

113 Followers

Dermata Therapeutics Financial Overview

Dermata Therapeutics's market cap is currently ―. The company's EPS TTM is $-21.424; its P/E ratio is -0.05; Dermata Therapeutics is scheduled to report earnings on March 31, 2025, and the estimated EPS forecast is $-1.50. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue--$ 6.90M--
Gross Profit--$ 6.90M--
EBIT$ -3.17M$ -2.83M$ -3.13M$ -2.22M$ -1.81M
EBITDA$ -3.17M$ -2.83M$ -3.13M$ -2.22M$ -1.81M
Net Income Common Stockholders$ -3.17M$ -2.83M$ -3.13M$ -2.13M$ -1.72M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 0.00$ 0.00$ 0.00$ 0.00$ 6.63M
Total Assets$ 6.69M$ 5.24M$ 5.18M$ 7.98M$ 7.32M
Total Debt$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Net Debt$ 0.00$ 0.00$ 0.00$ 0.00$ -6.63M
Total Liabilities$ 1.95M$ 1.92M$ 1.37M$ 1.62M$ 916.82K
Stockholders Equity$ 4.74M$ 3.32M$ 3.81M$ 6.36M$ 6.41M
Cash Flow-
Free Cash Flow$ -3.42M$ -2.13M$ -2.70M$ -1.15M$ -1.77M
Operating Cash Flow$ -3.42M$ -2.13M$ -2.70M$ -1.15M$ -1.77M
Investing Cash Flow-----
Financing Cash Flow$ 4.62M$ 2.34M-$ 1.95M$ -35.42K
Currency in USD

Dermata Therapeutics Earnings and Revenue History

Dermata Therapeutics Debt to Assets

Dermata Therapeutics Cash Flow

Dermata Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis